Ultragenyx Pharmaceutical Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ultragenyx Pharmaceutical Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q4 2023.
  • Ultragenyx Pharmaceutical Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $23.9M, a 8.08% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $23.9M -$2.1M -8.08% Dec 31, 2023 10-K 2024-02-21
Q3 2023 $26.4M -$2.32M -8.08% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $19.2M -$12M -38.5% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $22.9M -$9.75M -29.8% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $26M -$8.94M -25.6% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $28.8M -$7.95M -21.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $31.2M -$7.37M -19.1% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 $32.7M -$5.81M -15.1% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $34.9M -$5.59M -13.8% Dec 31, 2021 10-K 2023-02-17
Q3 2021 $36.7M -$901K -2.4% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $38.6M +$1.55M +4.19% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $38.5M +$2.68M +7.49% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $40.5M +$10.2M +33.6% Dec 31, 2020 10-K 2022-02-15
Q3 2020 $37.6M +$5.89M +18.6% Sep 30, 2020 10-Q 2020-10-27
Q2 2020 $37.1M +$3.71M +11.1% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $35.8M +$12.8M +55.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $30.3M Dec 31, 2019 10-K 2021-02-12
Q3 2019 $31.7M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $33.4M Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $23M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.